Clinical Trials in North Carolina

North Carolina is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in North Carolina and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 406 actively recruiting studies with North Carolina sites out of 406 registered in total. The busiest research areas in North Carolina are Heart Failure, Breast Cancer, Advanced Solid Tumors. Leading sponsors running trials in the state include Duke University, Wake Forest University Health Sciences, AstraZeneca. By stage, North Carolina trials break down as Phase 1 (63), Phase 2 (113), Phase 3 (108), Phase 4 (17).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in North Carolina